These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 6587445)

  • 41. [Problems of risk in genetic engineering research].
    Shivtsov OV
    Vestn Akad Med Nauk SSSR; 1981; (2):77-83. PubMed ID: 6941553
    [No Abstract]   [Full Text] [Related]  

  • 42. Will the DNA guidelines wither away?
    Nature; 1980 Oct; 287(5782):473-4. PubMed ID: 6999363
    [No Abstract]   [Full Text] [Related]  

  • 43. Regulation of genetic engineering: less concern about Frankensteins but time for action on commercial production.
    Karny GM
    Univ Toledo Law Rev; 1981; 12(4):815-68. PubMed ID: 11649588
    [No Abstract]   [Full Text] [Related]  

  • 44. Proposed amendment of procedures for scale-up of organisms listed in Appendix C.
    Recomb DNA Tech Bull; 1984 Jun; 7(2):75-6. PubMed ID: 6548037
    [No Abstract]   [Full Text] [Related]  

  • 45. Introduction to recombinant DNA research, development and evolution of the NIH guidelines, and proposed legislation.
    Talbot B
    Univ Toledo Law Rev; 1981; 12(4):804-14. PubMed ID: 11649587
    [No Abstract]   [Full Text] [Related]  

  • 46. Is self-regulation enough today?: Evaluating the recombinant DNA controversy.
    Weiner C
    Health Matrix Clevel; 1999; 9(2):289-302. PubMed ID: 10787474
    [No Abstract]   [Full Text] [Related]  

  • 47. [Problems of safety in biotechnology. Products of genetic engineering and regulation of work with them].
    Vorob'ev AA; Chugasova VA; Korovkin VI
    Mol Gen Mikrobiol Virusol; 1987 Sep; (9):3-10. PubMed ID: 3323899
    [No Abstract]   [Full Text] [Related]  

  • 48. Large-scale procedures under the NIH guidelines.
    Milewski E
    Recomb DNA Tech Bull; 1982 Jun; 5(2):88-91. PubMed ID: 6959205
    [No Abstract]   [Full Text] [Related]  

  • 49. Meeting of the large-scale review working group of the recombinant DNA Advisory Committee.
    Recomb DNA Tech Bull; 1982 Dec; 5(4):192-8. PubMed ID: 6761794
    [No Abstract]   [Full Text] [Related]  

  • 50. Development of guidelines for field testing of plants modified by recombinant DNA techniques.
    Milewski E; Tolin SA
    Recomb DNA Tech Bull; 1984 Sep; 7(3):114-24. PubMed ID: 6595719
    [No Abstract]   [Full Text] [Related]  

  • 51. Department of Health and Human Services, Public Health Service, National Institutes of Health. Recombinant DNA Advisory Committee. Minutes of Meeting, September 29, 1986.
    Recomb DNA Tech Bull; 1987 Mar; 10(1):3-44. PubMed ID: 3475740
    [No Abstract]   [Full Text] [Related]  

  • 52. Proposed addition of prohibited experiments to the NIH guidelines.
    Recomb DNA Tech Bull; 1985 Mar; 8(1):17-28. PubMed ID: 3858923
    [No Abstract]   [Full Text] [Related]  

  • 53. Evolution of the NIH guidelines.
    Milewski EA
    Recomb DNA Tech Bull; 1981 Dec; 4(4):160-5. PubMed ID: 7029672
    [No Abstract]   [Full Text] [Related]  

  • 54. Biosafety committees come under scrutiny.
    Field K
    Chron High Educ; 2005 Apr; 51(34):A22-3. PubMed ID: 16018097
    [No Abstract]   [Full Text] [Related]  

  • 55. The Hazardous Substance and New Organisms law reform proposal in New Zealand.
    Kennedy LD
    Australas Biotechnol; 1993; 3(3):165-6. PubMed ID: 7763850
    [No Abstract]   [Full Text] [Related]  

  • 56. Office of Recombinant DNA Activities; recombinant DNA research: action under the guidelines. National Institutes of Health (NIH), PHS, DHHS. Notice of action under the NIH Guidelines for Research Involving Recombinant DNA Molecules (NIH Guidelines).
    Fed Regist; 1999 May; 64(90):25361-2. PubMed ID: 10558523
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The biotechnology revolution and its regulatory evolution.
    Hoffman DE
    Drake Law Rev; 1988-1989; 38(3):471-550. PubMed ID: 16086466
    [No Abstract]   [Full Text] [Related]  

  • 58. Regulating biotechnology.
    McGarity TO
    Issues Sci Technol; 1985; 1(3):40-56. PubMed ID: 11649701
    [No Abstract]   [Full Text] [Related]  

  • 59. RAC discussion on the construction of biological weapons.
    Milewski E
    Recomb DNA Tech Bull; 1982 Dec; 5(4):188-91. PubMed ID: 6962470
    [No Abstract]   [Full Text] [Related]  

  • 60. The regulation of biotechnology products as "toxics".
    Shanks PL; Gibbons SL
    Healthspan; 1985 Feb; 2(2):21-8. PubMed ID: 10289625
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.